Inotersen therapy of transthyretin amyloid cardiomyopathy

Autor:	Noel R. Dasgupta, Stacy M. Rissing, Merrill D. Benson, Jessica Smith, Jeesun Jung
Rok vydání:	2019
Předmět:	Male Pathology medicine.medical_specialty Amyloid Cardiomyopathy Oligonucleotides 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Internal Medicine medicine Humans Term effect In patient Cause of death Aged Amyloid Neuropathies Familial biology business.industry Amyloidosis Middle Aged medicine.disease Transthyretin biology.protein Female business Amyloid cardiomyopathy Cardiomyopathies 030217 neurology & neurosurgery
Zdroj:	Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 27(1)
ISSN:	1744-2818
Popis:	Background: Cardiomyopathy is a major cause of death in patients with systemic transthyretin amyloidosis. Long term effect of therapy designed to inhibit hepatic production of the amyloid precursor...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a182105c4a0d1a1cda077f502ad993a https://pubmed.ncbi.nlm.nih.gov/31713445 Zobrazit plný text záznamu